Search alternatives:
point decrease » point increase (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
3d point » end point (Expand Search), _ point (Expand Search), 5 point (Expand Search)
_ mg » _ m (Expand Search), _ g (Expand Search), _ ms (Expand Search)
point decrease » point increase (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
3d point » end point (Expand Search), _ point (Expand Search), 5 point (Expand Search)
_ mg » _ m (Expand Search), _ g (Expand Search), _ ms (Expand Search)
-
1
-
2
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
-
12
Rac1 activity rapidly decreases upon cell-cell adhesion in 3-D cell aggregates.
Published 2011“…High levels of active Rac1 at 0 minutes rapidly decreased (∼66%) within 5 minutes of cell-cell adhesion, and declined to a baseline level by 30 minutes (A). …”
-
13
Rac1 activity decreases in the presence of DECMA-1 and E-cadherin:Fc in 3-D cell aggregates.
Published 2011“…<p>3-D MDCK cell aggregates were incubated with 10 µg/ml of DECMA-1 monovalent Fab' fragments (A), or 10 µg/ml of purified E-cadherin:Fc extracellular domain (E), or 10 µg/ml of Fc protein (I) for the indicated times. …”
-
14
-
15
-
16
-
17
-
18
-
19
-
20